Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan:158:105326.
doi: 10.1016/j.jcv.2022.105326. Epub 2022 Nov 12.

SARS-CoV-2 antigen tests for screening of healthcare workers; experience with over 48,000 combined antigen tests and RT-PCR tests

Affiliations

SARS-CoV-2 antigen tests for screening of healthcare workers; experience with over 48,000 combined antigen tests and RT-PCR tests

A Piek et al. J Clin Virol. 2023 Jan.

Abstract

Background: To prevent spread to patients and co-workers, health care workers (HCWs) infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) should quickly be identified. Although real time polymerase chain reaction (RT-PCR) is the gold standard, this test takes several hours, during which a HCW is unable to work. Antigen (Ag) tests may be an efficacious means of screening HCWs since they are easy to perform and provide fast results.

Methods: In this study, 48,010 paired results of Ag-testing and RT-PCR, performed on HCWs between January 2021 and April 2022, were evaluated to determine the diagnostic accuracy of SARS-CoV-2 Ag-tests in diagnosing potentially infectious individuals. This analysis was performed with cycling threshold values (Ct-values) ≤30 and ≤25 as cut-offs.

Results: Respectively 3.1% (n = 1507) and 0.3% (n = 140) of Ag-tests were positive or indeterminate, and thus indicative for SARS-CoV-2 infection. In total, 2479 (5.2%) RT-PCRs were positive, of which 1529 (61.7%) had a Ct-value ≤25 and 402 (16.2%) a Ct-value between 26 and 30. At Ct-value ≤30 as a cut-off, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of Ag-tests were 79.0%, 99.8%, 93.8% and 99.1%, respectively. At Ct-value ≤25, sensitivity further improved to 92.0%, by which the NPV increased to 99.7%.

Conclusions: To prevent transmission from HCWs to patients and co-workers, while maintaining workforce capacity, Ag-tests are a valuable addition to RT-PCR tests, as they have a quick turnaround time and excellent sensitivity for identifying individuals with high potential for transmission.

Keywords: Antigen test; Health care worker; Hospital management; Infection prevention; Real-time polymerase chain reaction; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interests.

Figures

Fig. 1
Fig. 1
Schematic overview of health care worker testing regime. Health care worker (HCW) screening was divided into five different phases. Phase 1 (T = 0 min) was generally performed by the health care worker himself/herself. Indication for testing was based on (1) signs and/or symptoms of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 infection), (2) close contact with a known positive person, or (3) after travelling to endemic areas as defined by the European Center of Disease Prevention and Control (ECDC) [2,5,6]. In phase 2 (T = 0 min), the test regime was determined. Asymptomatic or mild-symptomatic individuals planning to go to work in the University Medical Center Groningen (UMCG) (instead of at home) on the day of testing were tested with both a SARS-CoV-2 antigen (Ag) test and a SARS-CoV-2 Real-time polymerase chain reaction (RT-PCR). Otherwise, only SARS-CoV-2 RT-PCR was performed. In phase 3 (T = 15–30 min), based on the Ag-test result, it was decided whether a HCW was allowed to work at location awaiting the RT-PCR result (i.e. when the Ag-test result was negative), or should await the PCR result at home (when the Ag-test result was indeterminate (IND) or positive). In phase 4 (T ≤ 8 h), based on the RT-PCR result, the final decision was made on whether a HCW was allowed to work at location or should go into isolation.
Fig. 2
Fig. 2
Number of screenings per health care worker, Ag-test types and test results. (A) The number of tests for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection performed per individual health care worker (HCW) for the population tested with the combination of an antigen (Ag) test and Real-time polymerase chain reaction (RT-PCR) (n = 48,010 tests, n = 10,381 HCWs). Bars represent the total number of HCWs, colors represent the total number of screenings per individual HCW (ranging from 1 screening to over 31 screenings per HCW). (B) Types of Ag-tests used to screen HCWs for SARS-CoV-2 during the dominancy of Alpha, Delta and Omicron SARS-CoV-2 variants. Included population is the population screened with both RT-PCR and Ag-test (n = 48,010 tests). (C-D) Test results of (C) Ag-tests and (D) RT-PCR tests. The total circle represents all tests (n = 48,010), and different sections of the circle the part of total. See Supplemental Table 2 for exact numbers per section.
Fig. 3
Fig. 3
Association of Ag-test diagnostic accuracy with RT-PCR Ct-values. (A) Distribution of Cycling threshold values (Ct-values) as acquired by real time polymerase chain reaction (RT-PCR) for false negative antigen (Ag) test results (black bars) and true positive Ag-test results (pink bars). RT-PCR results were taken as the reference standard for the Ag-tests. Bin Center=1. Bars represent absolute numbers. (B) Sensitivity (red dots) and specificity (green squares) of the Ag-tests at different Ct-value cut-offs as reference standard. Sensitivity and specificity are represented as percentages.

Similar articles

Cited by

References

    1. World Health Organisation. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int (accecced 23 August 2022).
    1. Stockholm; ECDC: 2022. European Centre for Disease Prevention and Control. Assessment of the Further Spread and Potential Impact of the SARS-CoV-2 Omicron variant of Concern in the EU/EEA, 19th Update - 27 January 2022.
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
    1. ECDC; Stockholm: 2022. European Centre for Disease Prevention and Control. Guidance on Ending the Isolation Period for People with COVID-19, Third update, 28 January 2022.